ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ARRY Array Technologies Inc

13.74
0.28 (2.08%)
After Hours
Last Updated: 21:42:18
Delayed by 15 minutes
Share Name Share Symbol Market Type
Array Technologies Inc NASDAQ:ARRY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.28 2.08% 13.74 13.60 13.90 13.94 13.453 13.56 3,931,469 21:42:18

Array BioPharma To Present At The Stifel 2016 Healthcare And Jefferies 2016 Global Healthcare Conferences

08/11/2016 7:00pm

PR Newswire (US)


Array Technologies (NASDAQ:ARRY)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Array Technologies Charts.

BOULDER, Colo., Nov. 8, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:  www.arraybiopharma.com.   

Event:    

Stifel 2016 Healthcare Conference

Date:   

Tuesday, November 15, 2016

Time:    

10:15 a.m.  Eastern Standard Time



Event:                 

Jefferies 2016 Global Healthcare Conference

Date:               

Thursday, November 17, 2016

Time:            

5:20 p.m.  Greenwich Mean Time

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-stifel-2016-healthcare-and-jefferies-2016-global-healthcare-conferences-300359249.html

SOURCE Array BioPharma Inc.

Copyright 2016 PR Newswire

1 Year Array Technologies Chart

1 Year Array Technologies Chart

1 Month Array Technologies Chart

1 Month Array Technologies Chart

Your Recent History

Delayed Upgrade Clock